| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.05 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.08 | 0.05 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.05 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.05 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.05 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.23 | 0.05 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.36 | 0.05 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.05 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.065 | 0.06 |